Synthesis, Identification, and Characterization of a Novel 1,2,5‐Selenadiazole Derivative as a Microtubule Targeting Agent That Overcomes Multidrug Resistance
Archiv der Pharmazie · 2025
DOI: 10.1002/ardp.70087 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archiv der Pharmazie, 2025. Verfasst von Farhat Firdous und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and Chemical Engineering, Syed Babar Ali School of Science and Engineering, Lahore University of Management Sciences, Lahore,…. Hauptthemen laut MEDLINE: Microtubules, Antineoplastic Agents, Drug Resistance, Neoplasm, Drug Resistance, Multiple. Die Arbeit nennt 47 Literaturangaben. Gefördert von: This study received support from two Faculty Initiatives Fund grants (FIF-842) and (FIF-406) awarded by the Lahore University of Management Sciences (LUMS) to….
Abstract (Originalsprache)
Microtubules are crucial for various cellular processes, including cell division, where they form highly dynamic spindle fibers for chromosomal alignment and segregation. Interference with microtubule dynamics through microtubule targeting agents (MTAs) blocks progression through mitosis, ultimately resulting in apoptosis. Although MTAs have been effectively used as a frontline treatment for various cancers, multidrug resistance (MDR) often limits their effectiveness. This study focuses on selenadiazoles, a group of organic selenium compounds with anticancer activities. Eighteen novel 1,2,5‐selenadiazole derivatives were synthesized, three of which ( 9d , 9f , and 9i ) showed potent antiproliferative activity in HCT116 colorectal cancer cells. Treatment of cells with 9f (SSE1706), one of the most potent compounds (GI 50 value of 1.89 ± 0.99 µM), disrupted mitotic spindle formation, leading to G2/M arrest. 9f inhibited microtubule polymerization in cell‐based assays, and long‐term treatment with 9f stabilized p53 and induced apoptosis. Moreover, 9f effectively inhibited the growth of mouse and human colon cancer‐derived organoids. Finally, 9f exhibited potent antiproliferative activity against MDR‐1 overexpressing KB‐V1 cells, highlighting its potential to overcome MDR. These findings suggest 9f as a lead compound for further optimization studies, particularly targeting MDR.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry and Chemical Engineering, Syed Babar Ali School of Science and Engineering, Lahore University of Management Sciences, Lahore, Pakistan.
- Department of Life Sciences, Syed Babar Ali School of Science and Engineering, Lahore University of Management Sciences, Lahore, Pakistan.
- Institute of Genetics and Cancer, The University of Edinburgh, Western General Hospital Campus, Crewe Road, Edinburgh, EH4 2XU, Scotland.
- Department of Nanomedicine, Institute for Research and Medical Consultations (IRMC), Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia.
- KAUST Core Labs, King Abdullah University of Science and Technology, Thuwal, Kingdom of Saudi Arabia.
- Division of Biological and Environmental Sciences and Engineering, King Abdullah University of Science and Technology, Thuwal, Kingdom of Saudi Arabia.
ORCID-Profile: Sebastian Öther-Gee Pohl, Ghayoor Abbas, Rahman Shah Zaib Saleem, Amir Faisal
Förderung
- This study received support from two Faculty Initiatives Fund grants (FIF-842) and (FIF-406) awarded by the Lahore University of Management Sciences (LUMS) to…
Zitieren
APA
Firdous, F., Farrukh, S. U. B., Furqan, M., Shaukat, S., Fozail, S., Pohl, S. Ö., Akan, A. B., Myant, K. B., Alahmari, F., Emwas, A. H., Jaremko, M., Abbas, G., Saleem, R. S. Z., & Faisal, A. (2025). Synthesis, Identification, and Characterization of a Novel 1,2,5‐Selenadiazole Derivative as a Microtubule Targeting Agent That Overcomes Multidrug Resistance. Archiv der Pharmazie. https://doi.org/10.1002/ardp.70087
Vancouver
Firdous F, Farrukh SUB, Furqan M, Shaukat S, Fozail S, Pohl SÖ, et al. Synthesis, Identification, and Characterization of a Novel 1,2,5‐Selenadiazole Derivative as a Microtubule Targeting Agent That Overcomes Multidrug Resistance. Archiv der Pharmazie. 2025. doi:10.1002/ardp.70087
BibTeX
@article{Firdous2025,
author = {Firdous, Farhat and Farrukh, Syed Usama Bin and Furqan, Muhammad and Shaukat, Sana and Fozail, Salman and Pohl, Sebastian Öther-Gee and Akan, Aslıhan Bastem and Myant, Kevin B and Alahmari, Fatimah and Emwas, Abdul-Hamid and Jaremko, Mariusz and Abbas, Ghayoor and Saleem, Rahman Shah Zaib and Faisal, Amir},
title = {Synthesis, Identification, and Characterization of a Novel 1,2,5‐Selenadiazole Derivative as a Microtubule Targeting Agent That Overcomes Multidrug Resistance},
journal = {Archiv der Pharmazie},
year = {2025},
doi = {10.1002/ardp.70087}
}
EUVIMED